Filter by: patients
Home > Community Treatment Reports and Side Effects > Glatiramer acetate Treatment Report
What is Glatiramer acetate?

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 4202 1375 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 116 24 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
General health 57 25 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Stiffness/Spasticity 29 3 Efficacy_none Efficacy_cant_tell
Fatigue 25 10 Efficacy_major Efficacy_slight Efficacy_none Efficacy_cant_tell
Don't know 19 5 Efficacy_slight Efficacy_cant_tell

See all 3462 patients currently taking Glatiramer acetate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 165
Moderate
 243
Mild
 659
None
 365

Commonly reported side effects, conditions, and hospitalizations associated with Glatiramer acetate

Injection site reaction 343
Lumps and bumps 292
Injection site itching 263
Injection site pain 250
Redness 241
Bruising 161
See all 293 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Glatiramer acetate. See all 46 dosages ►

  daily 1 mg daily 1 mL daily 20 mg weekly 20 mg every other day 10 mg daily 20 mg daily 30 mg daily 40 mg daily 200 mg daily
  212 Number of Patients: 212 40 Number of Patients: 40 9 Number of Patients: 9 8 Number of Patients: 8 140 Number of Patients: 140 13 Number of Patients: 13 2938 Number of Patients: 2938 6 Number of Patients: 6 13 Number of Patients: 13 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 687   Did not seem to work: 40%
Side effects too severe 562   Side effects too severe: 32%
Doctor's advice 489   Doctor's advice: 28%
Other 341   Other: 20%
Expense 136   Expense: 8%
Personal research 102   Personal research: 6%
Change in health plan coverage 58   Change in health plan coverage: 3%
Course of treatment ended 26   Course of treatment ended: 1%
Not indicated 24   Not indicated: 1%

See all 1660 patients who’ve stopped taking Glatiramer acetate

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Glatiramer acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Glatiramer acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Glatiramer acetate

Always
 1080 75%
Usually
 285 20%
Sometimes
 37 3%
Never
 30 2%

Burden

Difficulty being on treatment

Burden of Glatiramer acetate

Very
 139 10%
Somewhat
 314 22%
A little
 521 36%
Not at all
 458 32%

Cost

Paid out of pocket

Cost of Glatiramer acetate

$200+
 121 11%
$100-199
 65 6%
$50-99
 112 10%
$25-49
 257 24%
< $25
 514 47%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.